Study of depression treatment effects on control and behavior
Part of Mental health clinical trials.
This trial looks at how antidepressant medication (SSRIs or SNRIs) changes a person's sense of control and behavior. It compares depressed patients starting treatment with healthy volunteers, and involves computer tasks and questionnaires over 8 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have mild-to-moderate depression and are about to start an SSRI or SNRI antidepressant (with or without a short-acting benzodiazepine) for the first time in this episode.
- You have not taken antidepressants, mood stabilizers, or antipsychotics in the past 3 years.
- You do not have a history of bipolar disorder, schizophrenia, or other psychotic disorders.
- You have not had a major depressive episode in the last 3 years.
- You are fluent in French, have internet access, and can attend study visits for 8 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.
This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.
This study tests whether a combination of cognitive training (brain exercises) and a medication (guanfacine or sertraline) can improve thinking skills in people with depression. It involves MRI scans and computer tasks to understand how your brain responds.
This trial studies how brain signals measured by MRI and EEG may help doctors choose the best treatment for depression. It focuses on people with early-onset, long-lasting or recurring major depression, and tests whether these “brain biomarkers” track with treatment choice and response.
This trial tests a personalized approach to treating major depressive disorder using assessments and brain imaging to match you with the best therapy. It aims to improve outcomes by tailoring care to your specific needs.
Hear when a new Depression Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.